Latest Updates

Primary and Metastatic Central Nervous System Malignancies

    • The main function of corticosteroids in CNS tumors is to control brain and spinal cord vasogenic edema and decrease intracranial pressure. Corticosteroids should be used with caution because of its significant side effects, such as insomnia, hyperglycemia, myopathy, psychiatric effects, and opportunistic infections. 
    • Maximal safe resection is recommended for all glioma grades and subtypes if the tumor is surgically accessible and there are no absolute medical contraindications to surgery. Nevertheless, even a macroscopic complete resection is almost never curative because grade II to IV gliomas infiltrate the normal brain.
    • The addition of WBRT to either surgical resection or radiosurgery decreases the risk of brain metastasis recurrence but does not improve survival in patients with one to three brain metastases.

Clinical Trial Design and Statistics

    • Because of the complex nature of clinical trial design, significant resources and infrastructure are invested in drug development. Many drugs fail to progress beyond the phase I/II stage, and many phase III trials take years to accrue and publish results, leading to a delay in Food and Drug Administration (FDA) approval for diseases that desperately need better therapeutic options. The relatively recent FDA Safety and Innovation Act has allowed for the creation of priority and expedited review for drugs and biologics in serious conditions and where there is an unmet medical need. The designation of fast-track or breakthrough therapy may be granted when there is preclinical or clinical evidence to suggest that the intervention may result in a substantial improvement over currently available therapies. 
    • Prior to embarking on a clinical trial, data entry, editing (“cleaning”), and analysis should be anticipated. Planning for data management begins with developing rules for coding the variables for computer entry. The appropriate hardware and software programs should be selected and standardized across study sites.
    • A type I error (false positive) occurs if an investigator rejects a null hypothesis that is true in the population. A type II error (false negative) occurs if the investigator fails to reject a null hypothesis that is false in the population. Neither of these errors can be avoided entirely.

Bipolar Disorders and Their Clinical Management, Part I: Epidemiology, Etiology, Genetics, and Neurobiology

    • Review of emerging genetics and etiologic theories of bipolar disorders
    • Correlation between recent neurobiologic findings and clinical manifestations of bipolar disorders
    • Discussion of the role of endocrine and immune alterations in metabolic derangements associated with bipolar disorders

Initial Management of Life-Threatening Trauma

    • Initial volume resuscitation should commence with 1 L isotonic crystalloid solution followed by blood products at 1:1:1 ratio (1 unit packed red blood cells to 1 unit fresh frozen plasma to 1 unit platelets) if the patient is not responsive to the initial fluid bolus.
    • In patients with massive hemorrhage or evidence of fibrinolysis, tranexamic acid has demonstrated improved survival if administered within 3 hours of injury.
    • Use of resuscitative endovascular balloon occlusion of the aorta may be an important adjunct in the control of life-threatening abdominal or pelvic hemorrhage.
    • In cases of external hemorrhage of an extremity, a tourniquet should be used to control bleeding.

CSF leak and encephalocele

    • The proportion of spontaneous CSF leaks is increasing and appears to be related to increasing prevalence of obesity and obstructive sleep apnea
    • Resolution of obesity and obstructive sleep apnea may prevent CSF leak recurrence, development of a leak at another site, or even allow a CSF leak to heal without surgery
    • Intracranial hypertension is now being recognized as a cause for other otologic and non-otologic symptoms such as headaches and pulsatile tinnitus

Bipolar Disorders and Their Clinical Management, Part I: Epidemiology, Etiology, Genetics, and Neurobiology

    • Review of emerging genetics and etiologic theories of bipolar disorders
    • Correlation between recent neurobiologic findings and clinical manifestations of bipolar disorders
    • Discussion of the role of endocrine and immune alterations in metabolic derangements associated with bipolar disorders

Initial Management of Life-Threatening Trauma

    • Initial volume resuscitation should commence with 1 L isotonic crystalloid solution followed by blood products at 1:1:1 ratio (1 unit packed red blood cells to 1 unit fresh frozen plasma to 1 unit platelets) if the patient is not responsive to the initial fluid bolus.
    • In patients with massive hemorrhage or evidence of fibrinolysis, tranexamic acid has demonstrated improved survival if administered within 3 hours of injury.
    • Use of resuscitative endovascular balloon occlusion of the aorta may be an important adjunct in the control of life-threatening abdominal or pelvic hemorrhage.
    • In cases of external hemorrhage of an extremity, a tourniquet should be used to control bleeding.

Bipolar Disorders and Their Clinical Management, Part I: Epidemiology, Etiology, Genetics, and Neurobiology

    • Review of emerging genetics and etiologic theories of bipolar disorders
    • Correlation between recent neurobiologic findings and clinical manifestations of bipolar disorders
    • Discussion of the role of endocrine and immune alterations in metabolic derangements associated with bipolar disorders
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections